AlphAIalphai — Financial news for AI agents
StockNASDAQ · US · USDHealthcare · Medical Devices

$APYX

Apyx Medical Corp

Price · $APYXvia TradingView
AI sentiment · 7d2 articles
AUG 2net (bullish − bearish)AUG 8
Bullish
1
Neutral
1
Bearish
0
Insider · 30dFeed →

No SEC Form 4 filings for $APYX in the last 30 days.

Top stories · $APYXMore →
AUG 7·SEC EDGAR 8-KLow

Apyx Medical Corp (APYX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Apyx Medical Corp (APYX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 APYX MEDICAL CORPORATION 2026 SHARE INCENTIVE PLAN Section 1. Purpose. The purposes of the Apyx Medical Corporation 2026 Share Incentive Plan (the “Plan”) are to: (i) aid in maintaining and developing key employees capable of assuring the

AUG 6·SEC EDGAR 8-K

Apyx Medical Corp (APYX): Results of Operations and Financial Condition

Apyx Medical Corp (APYX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_970692.htm EXHIBIT 99.1 ex_970692.htm EXHIBIT 99.1 Apyx Medical Corporation Reports Second Quarter 2026 Financial Results • Reported total revenue of $13.9 million in the second quarter of 2026 primarily driven by 28% growth in the Surgical Aesthetics segment • Succe

JUN 17·SEC EDGAR 8-K

Apyx Medical Corp (APYX): Entry into a Material Definitive Agreement

Apyx Medical Corp (APYX) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 APYX MEDICAL CORPORATION 5115 Ulmerton Road Clearwater, Florida 33760 June 11, 2026 Stavros Vizirgianakis C/O Apyx Medical Corporation 5115 Ulmerton Road Clearwater, Florida 33760 Re: Appointment as Executive Chairman Dear Stavros: This l

APYX sentiment & insider activity

Over the past 7 days, alphai's AI scored 2 news stories mentioning APYX (Apyx Medical Corp). Coverage has skewed bullish: 1 bullish, 1 neutral, and 0 bearish.

Recent APYX coverage spans financial news, corporate actions and earnings.

What's driving APYX

  • This is a governance and equity-compensation filing, not an operating or financial update. It can still affect near-term sentiment via changes in leadership incentives and plan availability.

    SEC EDGAR 8-K · Aug 7, 2026

  • Q2 results and reaffirmed FY2026 revenue guidance, plus expanded FDA 510(k) clearance for AYON power liposuction, are near-term catalysts for APYX sentiment and estimates.

    SEC EDGAR 8-K · Aug 6, 2026

  • Board leadership change plus a large RSU grant can shift governance expectations, but it is not an operating or financial guidance catalyst.

    SEC EDGAR 8-K · Jun 17, 2026

  • The announcement of a $10 million public offering by Apyx Medical indicates increased capital raising activity, which could lead to short-term stock dilution but also signals company growth initiatives.

    Benzinga · Nov 18, 2025

  • Apyx Medical's announced $10 million public offering indicates a capital raise that could support growth initiatives. The offering may lead to short-term stock dilution but signals confidence in future prospects.

    GlobeNewswire · Nov 18, 2025

alphai scores every news story that mentions APYX with an AI model for sentiment and relevance, and aggregates insider trades from Apyx Medical Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $APYX

Score
AUG 7$APYXLowSEC EDGAR 8-K

Apyx Medical Corp (APYX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Apyx Medical Corp (APYX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 APYX MEDICAL CORPORATION 2026 SHARE INCENTIVE PLAN Section 1. Purpose. The purposes of the Apyx Medical Corporation 2026 Share Incentive Plan (the “Plan”) are to: (i) aid in maintaining and developing key employees capable of assuring the

3 min read
AUG 6$APYXMedSEC EDGAR 8-K

Apyx Medical Corp (APYX): Results of Operations and Financial Condition

Apyx Medical Corp (APYX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_970692.htm EXHIBIT 99.1 ex_970692.htm EXHIBIT 99.1 Apyx Medical Corporation Reports Second Quarter 2026 Financial Results • Reported total revenue of $13.9 million in the second quarter of 2026 primarily driven by 28% growth in the Surgical Aesthetics segment • Succe

6 min read
JUN 17$APYXLowSEC EDGAR 8-K

Apyx Medical Corp (APYX): Entry into a Material Definitive Agreement

Apyx Medical Corp (APYX) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 APYX MEDICAL CORPORATION 5115 Ulmerton Road Clearwater, Florida 33760 June 11, 2026 Stavros Vizirgianakis C/O Apyx Medical Corporation 5115 Ulmerton Road Clearwater, Florida 33760 Re: Appointment as Executive Chairman Dear Stavros: This l

2 min read

Related tickers

More in Medical Devices